Market closedADR
Pharming Group/$PHAR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pharming Group
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
Ticker
$PHAR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
382
Website
Pharming Group Metrics
BasicAdvanced
$572M
-
-$0.02
0.64
-
Price and volume
Market cap
$572M
Beta
0.64
52-week high
$9.65
52-week low
$7.74
Financial strength
Current ratio
3.776
Quick ratio
3.021
Long term debt to equity
47.382
Total debt to equity
50.623
Interest coverage (TTM)
-0.87%
Management effectiveness
Return on assets (TTM)
-1.25%
Return on equity (TTM)
-5.00%
Valuation
Price to revenue (TTM)
19.401
Price to book
2.59
Price to tangible book (TTM)
3.58
Price to free cash flow (TTM)
-2,227.423
Growth
Revenue change (TTM)
21.15%
Earnings per share change (TTM)
-0.34%
3-year revenue growth (CAGR)
14.33%
3-year earnings per share growth (CAGR)
-11.39%
Pharming Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Pharming Group stock?
Pharming Group (PHAR) has a market cap of $572M as of April 02, 2025.
What is the P/E ratio for Pharming Group stock?
The price to earnings (P/E) ratio for Pharming Group (PHAR) stock is 0 as of April 02, 2025.
Does Pharming Group stock pay dividends?
No, Pharming Group (PHAR) stock does not pay dividends to its shareholders as of April 02, 2025.
When is the next Pharming Group dividend payment date?
Pharming Group (PHAR) stock does not pay dividends to its shareholders.
What is the beta indicator for Pharming Group?
Pharming Group (PHAR) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.